Cyrano Therapeutics, a Delray Beach, FL-based regenerative medicine company, raised $9.0M in Series B funding.
The round was co-led by the Florida Opportunity Fund managed by DeepWork Capital and existing investors Lumira Ventures and Remiges Ventures.
The company intends to use the funds to advance FLAVOR, its Phase 2, double-blind, randomized clinical trial of CYR-064, an intranasal theophylline spray therapy to treat patients who have lost their sense of smell following recovery from a viral infection.
Led by Rick Geoffrion, President and CEO, Cyrano Therapeutics is a clinical stage regenerative medicine company developing therapies for people struggling with the loss of smell and taste.
The Phase 2 FLAVOR trial is a 150 subject randomized, double-blinded, placebo-controlled, multi-dose, multi-site clinical trial of CYR-064 for the treatment of post-viral hyposmia. The trial will be conducted at up to 15 sites in the US.
Congratulations to Cyrano Therapeutics on the outstanding achievement of raising $9.0M in Series B financing! 🌟💰 This significant investment is a demonstration to the strength of your vision and the potential impact of your therapeutic innovations. Wishing you continued success as you advance in your mission to make a positive difference in healthcare. Here’s to the next phase of growth, development, and groundbreaking advancements! 🚀💼 #CyranoTherapeutics #SeriesBSuccess #HealthcareInnovation~ Dr Shishir said Gupta founder & CEO of StartupLanes
About us: StartupLanes is an ecosystem for Startups and Investors. Collaborate or find a co-founder, it’s a platform for Entrepreneurs. We love startups! A place for Angel Investors and Venture Capitalists to find investing opportunities in startups. Validate your idea, Learn & Execute.
Startups looking for funding may apply through StartupLanes Funding Application.
Angel Investors Register Free to explore exciting startup investment opportunities.